You're dealing with acne that won't clear, hair thinning on top of your head, or dark coarse hair growing where it shouldn't. Your dermatologist treats the surface, but the root cause is hormonal. PCOS drives skin and hair symptoms through specific pathways that topical treatments alone can't fix.
Key Takeaways
- PCOS skin and hair symptoms are driven by excess androgens, primarily testosterone and its more potent form, DHT.
- Elevated insulin reduces SHBG, freeing more testosterone to act on skin, hair follicles, and oil glands.
- The same hormonal imbalance causes hair thinning on the scalp and excess hair growth on the face and body.
- Insulin resistance contributes to acanthosis nigricans (dark skin patches) and skin tags independently of androgen levels.
- Treatment works best when it targets the underlying hormonal drivers, not just the visible symptoms.
What PCOS Does to Androgens and Insulin
Polycystic ovary syndrome disrupts two major systems: androgen production and insulin signaling. In PCOS, the ovaries produce excess androgens, primarily testosterone and androstenedione. High levels of luteinizing hormone (LH) and insulin both stimulate the ovaries to make more of these hormones. At the same time, many women with PCOS develop insulin resistance, meaning cells don't respond efficiently to insulin, so the pancreas compensates by producing more.
This creates a feedback loop. Elevated insulin prevents the liver from making sex hormone-binding globulin (SHBG), a protein that binds to testosterone and keeps it inactive. With less SHBG, more testosterone circulates freely in the blood. Free testosterone is biologically active. It binds to androgen receptors in the skin, hair follicles, and sebaceous glands, triggering the visible changes that define the PCOS face and scalp.
Testosterone itself isn't the only player. Inside certain tissues, an enzyme called 5-alpha reductase converts testosterone into dihydrotestosterone (DHT), a much more potent androgen. DHT binds tightly to androgen receptors in hair follicles and oil glands, driving both hair miniaturization on the scalp and increased sebum production in the skin. This dual action explains why the same hormonal imbalance can cause hair loss on your head and excess hair growth on your face.
How Androgen Excess Affects Skin, Hair Follicles, and Oil Glands
Sebaceous glands and acne formation
In sebaceous glands, elevated androgens increase oil production, creating an environment where acne-causing bacteria thrive. The result is inflammatory acne, often cystic, concentrated along the jawline, chin, and lower cheeks. This distribution pattern reflects where androgen receptors are most concentrated.
Scalp follicles and hair loss
Scalp follicles, particularly at the crown and temples, are sensitive to DHT. When DHT binds to receptors in these follicles, it shortens the growth phase of the hair cycle and shrinks the follicle itself. Over time, thick terminal hairs become fine vellus hairs, leading to androgenic alopecia, or female pattern hair loss.
Facial and body hair growth
Hair follicles on the face, chest, abdomen, and back respond to androgens by converting vellus hairs into thicker, darker terminal hairs, a condition called hirsutism. The same androgen excess that thins hair on your scalp stimulates growth in areas where men typically have hair.
Why Insulin Resistance Darkens and Tags the Skin
When insulin levels stay chronically elevated, the hormone begins to interact with insulin-like growth factor (IGF-1) receptors in the skin. This triggers keratinocytes and fibroblasts to proliferate, thickening the skin and increasing pigmentation. The result is acanthosis nigricans, velvety, hyperpigmented patches that typically appear in body folds: the back of the neck, armpits, groin, and under the breasts.
Acanthosis nigricans isn't dirt, and it doesn't scrub off. It's a visible marker of what's happening metabolically. The darkened skin reflects insulin's effect on skin cell turnover and melanin production. In PCOS, this is often one of the earliest signs of insulin resistance, appearing before blood sugar levels become overtly abnormal.
Skin tags, small benign growths that protrude from the skin surface, also correlate with insulin resistance. They tend to cluster in the same areas as acanthosis nigricans. While the exact mechanism isn't fully understood, skin tags are associated with hyperinsulinemia and metabolic syndrome. Their presence suggests that insulin signaling is disrupted enough to affect skin cell behavior, making them a useful clinical clue even without lab work.
What Drives Androgen Levels and Insulin Sensitivity
Androgen excess in PCOS has multiple origins. The primary driver is ovarian androgen production, stimulated by elevated LH and insulin. But adrenal androgens, particularly DHEA-S (dehydroepiandrosterone sulfate), also contribute in some women. If DHEA-S levels are significantly elevated, it suggests the adrenal glands are part of the picture, not just the ovaries.
Insulin resistance is influenced by genetics, body composition, diet, and physical activity. Visceral fat, the fat stored around internal organs, is metabolically active and worsens insulin resistance. It releases inflammatory cytokines and free fatty acids that interfere with insulin signaling.
High intake of refined carbohydrates and added sugars spikes blood glucose and insulin repeatedly throughout the day, keeping insulin levels chronically elevated. Over time, cells become less responsive to insulin's signal, requiring even more insulin to achieve the same effect. Physical activity, particularly resistance training and high-intensity interval training, improves insulin sensitivity by increasing glucose uptake into muscle cells independent of insulin.
Chronic stress elevates cortisol, which raises blood sugar and promotes visceral fat accumulation. Sleep deprivation disrupts glucose metabolism and increases insulin resistance. Both factors worsen the hormonal environment that drives PCOS skin and hair symptoms.
Why the Same Diagnosis Produces Different Skin and Hair Patterns
Not every woman with PCOS experiences the same symptoms. Some have severe acne but no hair loss. Others lose hair rapidly but have clear skin. The difference lies in individual androgen sensitivity, enzyme activity, and the balance between ovarian and adrenal androgen production.
Genetic variation in androgen receptor genes affects how strongly tissues respond to circulating androgens. Two women with identical testosterone levels can have vastly different symptoms if one has more sensitive androgen receptors. Similarly, variation in 5-alpha reductase activity determines how much testosterone gets converted to DHT locally in the skin and scalp. Higher enzyme activity means more DHT, which translates to more severe acne and hair loss.
The ratio of ovarian to adrenal androgens also varies. Women with predominantly ovarian androgen excess often respond well to treatments that suppress ovarian function, like combined oral contraceptives. Those with elevated DHEA-S may need interventions that address adrenal androgen production or improve overall metabolic health. Testing both testosterone and DHEA-S helps clarify which pathway is dominant.
Insulin resistance severity also differs. Some women with PCOS have normal insulin sensitivity and no acanthosis nigricans or skin tags. Their symptoms are driven almost entirely by androgen excess. Others have profound insulin resistance with minimal androgen elevation. The presence or absence of darkened skin and skin tags provides a clinical clue about which metabolic pathway is most disrupted. Measuring fasting insulin, glucose, and hemoglobin A1c quantifies this.
Turning Symptoms Into Data and Data Into Strategy
Skin and hair changes in PCOS aren't cosmetic annoyances. They're visible readouts of hormonal and metabolic dysfunction. Tracking the biomarkers that drive these symptoms reveals which pathways are most active and how they're changing over time:
- Free testosterone and SHBG indicate androgen activity and how much testosterone is biologically available
- DHEA-S distinguishes between ovarian and adrenal androgen sources
- Insulin and glucose markers reveal the degree of insulin resistance driving metabolic symptoms
If androgen levels are high and insulin is normal, the priority is reducing androgen production or blocking androgen receptors. If insulin resistance is the dominant feature, improving insulin sensitivity through diet, exercise, and potentially medications like metformin becomes the focus. Often, both pathways are involved, and addressing one improves the other. Lowering insulin reduces ovarian androgen production. Reducing androgens can improve insulin sensitivity by decreasing visceral fat.
Monitoring changes in these markers over months shows whether interventions are working before symptoms fully resolve. Hair regrowth takes time. Acne improves in weeks to months. Acanthosis nigricans fades slowly as insulin sensitivity improves. But biomarkers shift faster, providing early feedback that you're moving in the right direction.
PCOS affects more than periods and fertility. It shows up on your face, your scalp, and your skin. Understanding the mechanisms behind these changes makes them less mysterious and more manageable. Superpower's 100+ biomarker panel tracks the hormones and metabolic markers that drive PCOS symptoms, so you can see exactly what's happening and adjust your approach based on data, not guesswork.


.avif)
.avif)

